-
Roth Upgrades NVIDIA To Buy, Encouraged By 'Deep Learning' Growth
Friday, May 13, 2016 - 8:10am | 240Read More...NVIDIA Corporation (NASDAQ: NVDA) reported excellent F1Q17 results, with both top and bottom line ahead of expectations. Roth Capital Partners’ Brian Alger upgraded the rating for the company from Neutral to Buy, while raising the price target from $34.50 to $40. The analyst commented that...
-
Diamondback Energy Is One To Keep An Eye On Should Crude Oil Prices Strengthen
Monday, May 9, 2016 - 10:11am | 378Read More...ROTH Capital Partners analyst John White believes Diamondback Energy Inc (NASDAQ: FANG) is one stock investors should keep an eye on, especially if crude oil prices strengthen. The analyst has a Neutral rating on the shares (the rating system itself has been changed, with "Hold" being replaced by "...
-
Digital Ally Will Remain Unprofitable Until 2017, Says Roth
Monday, May 9, 2016 - 9:36am | 327Read More...Digital Ally, Inc. (NASDAQ: DGLY) is scheduled to report its 1Q16 results after market close on May 10. ROTH Capital’s William Gibson maintains a Neutral rating on the company, with a price target of $6. ‘Minimal Sales Growth’ Gibson expects Digital Ally to witness “minimal...
-
Roth Concerned With 'Competitive, Pricing Uncertainties' At Cogentix Medical, Downgrades
Friday, May 6, 2016 - 10:04am | 242Read More...Cogentix Medical Inc (NASDAQ: CGNT) reported lower-than-expected 1Q16 revenues and GAAP net loss, but its operating cash generation was positive for the second consecutive quarter. Roth Capital Partners’ Chris Lewis downgraded the rating for the company from Buy to Neutral, with a price...
-
Roth Doesn't See Any Growth Catalysts At Glu Mobile, Downgrades To Neutral
Wednesday, May 4, 2016 - 9:58am | 322Read More...Glu Mobile Inc. (NASDAQ: GLUU) reported its 1Q results well ahead of the consensus and the estimates. ROTH Capital’s Darren Aftahi downgraded the rating on the company to Neutral, while lowering the price target from $4.15 to $2.50, due to the lack of growth catalysts. The analyst mentioned...
-
Roth Lowers First Solar's Target To $70, But Likes The Stock Long Term
Thursday, April 28, 2016 - 10:08am | 259Read More...First Solar, Inc. (NASDAQ: FSLR) reported mixed 1Q results, with the EPS ahead of expectations and revenue significantly missing the consensus forecasts. ROTH Capital’s Philip Shen maintains a Buy rating on the company, while lowering the price target from $80 to $70. Applauding the choice of...
-
It Won't Get Any Better For Redbox This Quarter
Tuesday, April 19, 2016 - 10:43am | 244Read More...Outerwall Inc (NASDAQ: OUTR) is scheduled to report its 1Q16 results on Thursday, April 28. Roth Capital Partners’ Darren Aftahi reiterated a Neutral rating for the company, with a price target of $35, saying that the company is likely to report another weak quarter for Redbox rentals....
-
Roth Starts FuelCell Energy At Buy, $12 Target, Cites Anticipated Orders
Monday, April 11, 2016 - 9:36am | 288Read More...FuelCell Energy Inc (NASDAQ: FCEL) has a $2bn pipeline with utility and industrial power customers. Roth Capital Partners’ Craig Irwin initiated coverage of the company with a Buy rating and a price target of $12, saying that the market seems to be underappreciating the company’s...
-
8point3: Nothing But Execution
Thursday, April 7, 2016 - 10:21am | 324Read More...8Point3 Energy Partners LP (NASDAQ: CAFD) reported its FQ1 results largely in line with expectations, while announcing its FQ2 guidance below expectations, primarily driven by the timing of distributions from its affiliates. ROTH Capital’s Philip Shen reiterated a Buy rating on the company,...
-
Ligand Partner Novartis Gets Key E.U. Approval: Roth Capital Likes It
Thursday, April 7, 2016 - 9:46am | 339Read More...The European Commission [EC] has expanded the label for Revolade [Promacta], developed by Ligand Pharmaceuticals Inc. (NASDAQ: LGND) partner Novartis AG (ADR) (NYSE: NVS), by approving the drug for children older than 1 year with chronic ITP. Roth Capital Partners’ Joseph Pantginis...
-
A Water Desalination Play With 2 Catalysts Coming Soon
Friday, March 25, 2016 - 2:01pm | 263Read More...In a new report, ROTH Capital Partners analyst Gerry Sweeny takes a look at what 2016 has in store for Consolidated Water Co. Ltd. (NASDAQ: CWCO). According to Sweeny, the stock has two bullish catalysts ahead this year. First, the Baja California Water Commission is expected to announce the...
-
Glu Mobile Will Likely Try Another Katy Perry Game After Flop
Friday, March 18, 2016 - 10:25am | 315Read More...Glu Mobile Inc. (NASDAQ: GLUU) may have experienced some recent lackluster performances, but the mobile gaming company remains determined. Recently, the company engaged in a "fireside chat" with Roth Capital Partners, during which the COO and CFO discussed the current mobile gaming situation. Three...
-
Outerwall Could Sell Itself Or Spin Off Assets, Roth's Aftahi Says
Tuesday, March 15, 2016 - 9:43am | 215Read More...Roth Capital Partners’ Darren Aftahi upgraded the rating for Outerwall Inc (NASDAQ: OUTR) from Sell to Neutral, while establishing a price target of $35. The analyst said that while the company’s core business continues to struggle, it could add value via strategic alternatives and a...
-
American Vanguard Is A Niche Player In Ag Chemicals
Friday, March 11, 2016 - 9:48am | 329Read More...ROTH Capital’s Joe Reagor initiated coverage on American Vanguard Corp. (NYSE: AVD) with a Buy rating and price target of $19. A Niche Player “We believe AVD is a unique niche player in the agricultural chemicals market and that the company is poised for additional growth in the...
-
Roth Sees Steady Recovery For Inventure Foods
Friday, January 15, 2016 - 10:07am | 295Read More...Inventure Foods Inc (NASDAQ: SNAK) shares have been trending southwards in the last one year and are down 56 percent. Roth Capital Partners’ Anton Brenner maintained a Buy rating for the company, with a price target of $12. The company is poised for a recovery in 2016, with overall...
